Lastly, because mutant ATXN3 stabilizes P53 leading to an increased abundance of p53 in MJD cellular models [21], future quantification of the P53 protein in peripheral blood from MJD carriers could reveal a new progression biomarker for MJD. This evidence concerns the gene ATXN3 and Machado-Joseph disease.